Coverage
-
November 07, 2025
Bankrupt drugmaker Purdue Pharma will begin a confirmation trial for its latest Chapter 11 plan Wednesday in a vastly different position than the last time it came to court seeking similar relief in 2021, when a New York judge approved a plan — over the objections of key parties — that was later struck down by the U.S. Supreme Court.
193 other articles on this case.
View all »